Table 4.
4a. All subjects | ||||||
---|---|---|---|---|---|---|
Parameter | Framingham Risk Score > 10% | Framingham General Cardiovascular Risk Score > 20% | Total : HDL Cholesterol Ratio > 5.0 | |||
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
WBC | 80.8 (2.8–2341) | 0.01 | 13.51 (1.25–146) | 0.03 | 2.54 (0.50–12.91) | 0.26 |
Neutrophils | 7.84 (1.14–55.43) | 0.04 | 3.60 (0.77–16.78) | 0.10 | 1.52 (0.53–4.36) | 0.44 |
Lymphocytes | 4.00 (1.23–12.99) | 0.02 | 2.21 (0.84–5.83) | 0.11 | 1.81 (0.81–4.07) | 0.15 |
Monocytes | 757 (6.6–86699) | 0.01 | 23.3 (0.60–902) | 0.09 | 51.2 (2.1–1247) | 0.02 |
hsCRP | 0.84 (0.48–1.46) | 0.54 | 1.21 (0.72–2.02) | 0.47 | 1.13 (0.77–1.65) | 0.54 |
4b. Males | ||||||
---|---|---|---|---|---|---|
Parameter | Framingham Risk Score > 10% | Framingham General Cardiovascular Risk Score > 20% | Total : HDL Cholesterol Ratio > 5.0 | |||
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
WBC | 2448 (5.1–1170597) | 0.01 | 16.47 (0.75–364) | 0.08 | 14.11 (1.27–158) | 0.03 |
Neutrophils | 29.2 (1.5–586) | 0.03 | 3.17 (0.44–22.94) | 0.25 | 3.24 (0.68–15.48) | 0.14 |
Lymphocytes | 28.4 (2.3–351) | 0.01 | 6.86 (0.93–50.81) | 0.06 | 3.27 (1.06–10.05) | 0.04 |
Monocytes | 1436 (2.3–909554) | 0.03 | 6.35 (0.02–1775) | 0.52 | 1867 (10.5–330811) | <0.01 |
hsCRP | 0.96 (0.48–1.93) | 0.91 | 1.27 (0.59–2.72) | 0.55 | 1.35 (0.77–2.38) | 0.30 |